Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 107 clinical trials
Plasma-Adapted First-Line Pembro In NSCLC

pemetrexed Carboplatin and paclitaxel The name of the blood test: InVision (Inivata, Ltd.)

neutrophil count
measurable disease
pd-l1
cancer
progressive disease
  • 1 views
  • 14 Jun, 2022
  • 3 locations
Phase III Randomized Trial of Pleurectomy/Decortication Plus Chemotherapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma (MPM)

. Targeted radiation therapy such as intensity-modulated radiation therapy or pencil beam scanning uses high energy rays to kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as pemetrexed

  • 0 views
  • 17 Sep, 2022
  • 4 locations
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

cells to grow and spread. Drugs used in chemotherapy, such as pemetrexed and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from

  • 0 views
  • 06 May, 2022
  • 441 locations
Phase II Study of Induction Checkpoint Blockade for Untreated Stage I-IIIA Non-Small Cell Lung Cancers Amenable for Surgical Resection

grow and spread. Drugs used in chemotherapy, such as cisplatin, docetaxel, and pemetrexed, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from

carcinoma
cancer chemotherapy
neutrophil count
lung carcinoma
docetaxel
  • 25 views
  • 21 Sep, 2022
  • 1 location
NASSIST (Neoadjuvant Chemoradiation +/- Immunotherapy Before Surgery for Superior Sulcus Tumors): A Randomized Phase II Trial of Trimodality +/- Atezolizumab in Resectable Superior Sulcus Non-Small Cell Lung Cancer

cisplatin, carboplatin, etoposide, paclitaxel and pemetrexed, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from

  • 0 views
  • 22 Sep, 2022
  • 30 locations
A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

cisplatin and pemetrexed for 4 cycles (every 21 days) will be given following surgery. After the completion of standard chemotherapy, optional adjuvant treatment with pembrolizumab will be given to eligible

resectable malignant pleural mesothelioma
international normalized ratio
neutrophil count
pleurectomy
thoracoscopy
  • 29 views
  • 23 Feb, 2022
  • 1 location
DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial (DREAM3R)

Patients with malignant pleural mesothelioma (MPM) that cannot be surgically removed will receive first-line treatment with standard chemotherapy of cisplatin or carboplatin and pemetrexed. Two

neutrophil count
gilbert's syndrome
measurable disease
cancer
chemotherapy regimen
  • 0 views
  • 18 Sep, 2022
  • 55 locations
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

consists of surgery or chemotherapy. Chemotherapy drugs, such as carboplatin and pemetrexed, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from

  • 0 views
  • 04 Oct, 2022
  • 20 locations
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer

drugs, such as carboplatin, pemetrexed, paclitaxel and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by

  • 0 views
  • 14 Sep, 2022
  • 44 locations
MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib (MELROSE)

survival was significantly longer with osimertinib than with platinum therapy plus pemetrexed (10.1 months vs. 4.4 months p<0.001). In addition, clinical data show that patients with mutated

carcinoma
epidermal growth factor receptor
egfr t790m
advanced lung cancer
kinase inhibitor
  • 6 views
  • 08 Feb, 2022
  • 4 locations